- Management of Antiviral Resistance in Chronic Hepatitis B
-
Lim YS
- KMID: 2412184
- Gut Liver.
- 2017 Mar;11(2):189-195.
- doi: 10.5009/gnl15562
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine Therapy for Korean Children with Chronic Hepatitis B
-
Koh H, Baek SY, Chung KS
- KMID: 1786205
- Yonsei Med J.
- 2007 Dec;48(6):927-933.
- doi: 10.3349/ymj.2007.48.6.927
PURPOSE: Lamivudine is known to be very effective in suppressing hepatitis B virus replication and virus induced necroinflammation. The aim of this study was to evaluate lamivudine therapy efficacy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Overlapping Gene Mutations of Hepatitis B Virus in a Chronic Hepatitis B Patient with Hepatitis B Surface Antigen Loss during Lamivudine Therapy
-
Lee SY, Choi MS, Lee D, Lee JH, Koh KC, Paik SW, Yoo BC
- KMID: 1778502
- J Korean Med Sci.
- 2005 Jun;20(3):433-437.
- doi: 10.3346/jkms.2005.20.3.433
Disappearance of hepatitis B surface antigens (HBsAg) in chronic hepatitis B usually indicates clearance of hepatitis B virus (HBV) infection. However, false HBsAg negativity with mutations in pre-S2 and 'a'... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
-
Seo HY, Lee HA, Ko SY, Wang JH, Kim JH, Choe WH, Kwon SY
- KMID: 2413119
- Clin Mol Hepatol.
- 2017 Jun;23(2):154-159.
- doi: 10.3350/cmh.2016.0067
BACKGROUND/AIMS: Little is known about the effect of early flares on response during first-line tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB). The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
-
Cho EY, Yim HJ, Jung YK, Suh SJ, Seo YS, Kim JH, Kim HS, Lee SH, Ahn SH, Lee JI, Jeong SH, Kim JW, Lee JW, Kim IH, Kim HS, Park SJ, Lee JM, Hwang SG
- KMID: 2412164
- Gut Liver.
- 2017 Jan;11(1):129-135.
- doi: 10.5009/gnl15597
BACKGROUND/AIMS: Data are lacking regarding the management of chronic hepatitis B (CHB) with resistance to clevudine (CLV). This study evaluated the efficacy of different rescue therapies for CLV-resistant CHB. METHODS: Patients... -
- CITED
-
- Close
- SHARE
-
- Close
